Literature DB >> 820877

Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors.

A Morales, D Eidinger, A W Bruce.   

Abstract

Patients with recurrent superficial bladder tumors have been treated by vesical and intradermal administration of Bacillus Calmette-Guerin. The pattern of recurrence in 9 patients has been altered favorably. Although the findings are still preliminary they appear to hold promise of a new therapeutic approach to the treatment of a group of neoplasms for which effective therapy is still lacking.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 820877     DOI: 10.1016/s0022-5347(17)58737-6

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  387 in total

Review 1.  Non-specific immunotherapy with bacille Calmette-Guérin (BCG).

Authors:  A P van der Meijden
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

2.  Replication-selective microbiological agents: fighting cancer with targeted germ warfare.

Authors:  D H Kirn
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

3.  Treatment of refractory interstitial cystitis.

Authors:  A Morales; L Emerson; J C Nickel
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1996

Review 4.  Microorganisms and cancer: quest for a therapy.

Authors:  A M Chakrabarty
Journal:  J Bacteriol       Date:  2003-05       Impact factor: 3.490

Review 5.  Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors.

Authors:  Shona Hendry; Roberto Salgado; Thomas Gevaert; Prudence A Russell; Tom John; Bibhusal Thapa; Michael Christie; Koen van de Vijver; M V Estrada; Paula I Gonzalez-Ericsson; Melinda Sanders; Benjamin Solomon; Cinzia Solinas; Gert G G M Van den Eynden; Yves Allory; Matthias Preusser; Johannes Hainfellner; Giancarlo Pruneri; Andrea Vingiani; Sandra Demaria; Fraser Symmans; Paolo Nuciforo; Laura Comerma; E A Thompson; Sunil Lakhani; Seong-Rim Kim; Stuart Schnitt; Cecile Colpaert; Christos Sotiriou; Stefan J Scherer; Michail Ignatiadis; Sunil Badve; Robert H Pierce; Giuseppe Viale; Nicolas Sirtaine; Frederique Penault-Llorca; Tomohagu Sugie; Susan Fineberg; Soonmyung Paik; Ashok Srinivasan; Andrea Richardson; Yihong Wang; Ewa Chmielik; Jane Brock; Douglas B Johnson; Justin Balko; Stephan Wienert; Veerle Bossuyt; Stefan Michiels; Nils Ternes; Nicole Burchardi; Stephen J Luen; Peter Savas; Frederick Klauschen; Peter H Watson; Brad H Nelson; Carmen Criscitiello; Sandra O'Toole; Denis Larsimont; Roland de Wind; Giuseppe Curigliano; Fabrice André; Magali Lacroix-Triki; Mark van de Vijver; Federico Rojo; Giuseppe Floris; Shahinaz Bedri; Joseph Sparano; David Rimm; Torsten Nielsen; Zuzana Kos; Stephen Hewitt; Baljit Singh; Gelareh Farshid; Sibylle Loibl; Kimberly H Allison; Nadine Tung; Sylvia Adams; Karen Willard-Gallo; Hugo M Horlings; Leena Gandhi; Andre Moreira; Fred Hirsch; Maria V Dieci; Maria Urbanowicz; Iva Brcic; Konstanty Korski; Fabien Gaire; Hartmut Koeppen; Amy Lo; Jennifer Giltnane; Marlon C Rebelatto; Keith E Steele; Jiping Zha; Kenneth Emancipator; Jonathan W Juco; Carsten Denkert; Jorge Reis-Filho; Sherene Loi; Stephen B Fox
Journal:  Adv Anat Pathol       Date:  2017-11       Impact factor: 3.875

6.  Granulomatous hepatitis, choroiditis and aortoduodenal fistula complicating intravesical Bacillus Calmette-Guérin therapy: Case report.

Authors:  Cindy Q Gao; Rozina Mithani; Jack Leya; Lesley Dawravoo; Arvin Bhatia; John Antoine; Felipe De Alba; Peter A Russo; Claus J Fimmel
Journal:  BMC Infect Dis       Date:  2011-09-30       Impact factor: 3.090

7.  Prognostic value of cystocopically pseudotumoral lesions (inflammation/granuloma) in primary stage T1 grade 3 bladder tumors treated with BCG.

Authors:  E Pieras-Ayala; J Palou-Redorta; J I Tomero-Ruiz; M Montlleó-González; J Salvador-Bayarri; J Vicente-Rodríguez
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

8.  Intravesical treatment of severe bacillus Calmette-Guerin cystitis.

Authors:  J Palou; L Rodríguez-Villamil; A Andreu-Crespo; J Salvador-Bayarri; J Vicente-Rodríguez
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

9.  A cough conundrum in a patient with a previous history of BCG immunotherapy for bladder cancer.

Authors:  Arpan R Mehta; Puja R Mehta; Rajesh L Mehta
Journal:  BMJ Case Rep       Date:  2012-10-24

10.  Can intravesical bacillus Calmette-Guérin reduce recurrence in patients with non-muscle invasive bladder cancer? An update and cumulative meta-analysis.

Authors:  Jiangang Pan; Mo Liu; Xing Zhou
Journal:  Front Med       Date:  2014-05-08       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.